Medline Inc (MDLN) Sharpe Ratio

Sharpe ratio is not yet available for MDLN. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares Medline Inc's Sharpe Ratio with other stocks in the Medical Instruments & Supplies industry across multiple time periods, showing how MDLN's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 4, 2026.

Symbol	Name	1Y Sharpe Ratio
NNNN	Anbio Biotechnology Class A	1.62
HOCPY	Hoya Corp	1.45
AVR	Anteris Technologies Global Corp	1.26
WST	West Pharmaceutical Services, Inc.	1.23
BLCO	Bausch + Lomb Corp	0.94
STAA	STAAR Surgical Company	0.94
INFU	InfuSystem Holdings Inc.	0.92
UTMD	Utah Medical Products, Inc.	0.83
PDEX	Pro-Dex, Inc.	0.81
KRMD	Repro Med Systems, Inc.	0.73
MDLN	Medline Inc	—

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows MDLN's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when MDLN consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does MDLN fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio